To strictly manage risks, medical systems usually adopt technologies that matured yesterday. The market promotion of AI innovative technology applications is facing challenges, and relevant regulations must also keep pace with the times.
The medical equipment industry is a cross-disciplinary technology industry with a number of diverse industrial characteristics. With changes in disease patterns, product development, and medical technology advancements, its mainstream products will become increasingly advanced. Countries have invested considerable resources and consider the development of medical products a key priority.
The global population is rapidly seeing an irreversible trend to longer lifespans, and this trend will inevitably lead to an increase in chronically ill patients. To meet the needs of an aging society, the pursuit of better medical services and quality medical products has become a common global issue.
Developments in medical technology are increasing rapidly, and are no longer limited to drugs or medical equipment. Artificial intelligence, 3D printing technology, virtual reality (VR), and big data, which once only appeared in science fiction or movies, are now being used to treat or prevent diseases, leading medical technology into a new era.
With the advancement and development of medical technology (such as the use of new drugs, new surgical procedures, the use of new treatments, genetic screening, etc.), many severe or critical illnesses can be alleviated or cured, high-risk surgeries can be made less terrifyingly, and genetic diseases that were previously undetectable can be screened in advance and properly dealt with.
The growth of the overall global biotech pharmaceutical market is slowing down. Europe and the United States have entered a mature period, and global development in the overall biotech pharmaceutical industry market has slowed down in recent years.
In the face of the spread of the epidemic, people minimize their chances of contacting people when going out, but how should the necessary medical services be solved? The telemedicine consultation will be used to advance subordinates and provide remote medical interviews and consultations that do not require contact.
Artificial intelligence, 5G, and the Internet of Everything are changing our medical behavior. Under the catalysis of COVID-19, telehealth is accelerating its maturity. The so-called telehealth is not only remote video visits but also includes remote medical technology such as telehealth monitoring.
According to market statistics and estimates, the telemedicine market will be worth 45 billion U.S. dollars in 2019. Affected by the COVID-19 epidemic, the telemedicine market is estimated to have a compound annual growth rate of 19.3% from 2020 to 2026. The scale will grow to 175.5 billion US dollars.
Due to the increases in demands for epidemic related drugs, screening reagents, and other products driven by the epidemic, the output values of drugs, medical supplies, and other related products have been increased.
Observing key trends in the global health care industry, analyzing the current status of global and Taiwan medical device development, and analyzing the growth strategy of Taiwan's medical device industry.
The medical device industry is transforming. Nearly 80% of medical material companies believe that medical networking is the most important growth opportunity in the future, and 45% believe that cooperation with strategic partners is necessary. In fact, for medical IT solution vendors, the next decade is also an opportunity for their growth.
Artificial intelligence (AI) has the potential to transform how healthcare is delivered. A joint report with the European Union’s EIT Health explores how it can support improvements in care outcomes, patient experience, and access to healthcare services.